Compounds That Target LYN

LYN proto-oncogene, Src family tyrosine kinase · 68 compounds in BiohacksAI corpus

LYN (LYN proto-oncogene, Src family tyrosine kinase) is a biological target with 68 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into LYN modulation for therapeutic and biohacking applications.

View LYN target page →

All 50 Compounds — Ranked by Evidence

Gefitinib

5.67

confidence

Erlotinib

5.55

confidence

Imatinib

5.47

confidence

Ibrutinib

4.86

confidence

Cabozantinib

4.39

confidence

Foretinib

4.34

confidence

Tozasertib

4.33

confidence

Vandetanib

4.30

confidence

Ponatinib

4.26

confidence

Ceritinib

4.19

confidence

Nilotinib

4.17

confidence

Bosutinib

4.08

confidence

Doramapimod

4.06

confidence

Quizartinib

3.99

confidence

Midostaurin

3.85

confidence

Brigatinib

3.81

confidence

Pazopanib

3.69

confidence

Neratinib

3.66

confidence

Nintedanib

3.61

confidence

Canertinib

3.53

confidence

Pelitinib

3.50

confidence

Tae 684

3.43

confidence

Fedratinib

3.40

confidence

Mln 8054

3.33

confidence

Saracatinib

3.33

confidence

Dabrafenib

3.30

confidence

Neflamapimod

3.30

confidence

Dovitinib

3.09

confidence

At 9283

3.09

confidence

Dasatinib Anhydrous

3.09

confidence

Lestaurtinib

3.04

confidence

Spebrutinib

3.04

confidence

Danusertib

2.94

confidence

Defosbarasertib

2.89

confidence

Barasertib

2.89

confidence

R 406

2.83

confidence

Cediranib

2.83

confidence

Milciclib

2.77

confidence

Infigratinib

2.77

confidence

Masitinib

2.77

confidence

Plx 4720

2.71

confidence

Kw 2449

2.64

confidence

Tivozanib

2.64

confidence

Ast 487

2.56

confidence

Atuveciclib

2.56

confidence

Raf 265

2.48

confidence

Defactinib

2.48

confidence

Motesanib

2.48

confidence

Cudc 101

2.40

confidence

Tak 285

2.40

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for LYN (LYN proto-oncogene, Src family tyrosine kinase). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: LYN target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.